pharmaceuticals founded 2002 2002 headquarters saint genis pouilly france key people stefano buono ceo claudio costamagna chairman products gluscan dopaview iasocholine iasodopa iasoflu mibitec leukokit revenue 88.6 million number of employees 460 website adacap.com advanced accelerator applications aaa nasdaq aaap is a pharmaceutical group specialised in the field of molecular nuclear medicine . 1 the group operates in all three segments of molecular nuclear medicine pet spect and therapy to diagnose and treat serious conditions in the fields of oncology cancer neurology cardiology infectious and inflammatory diseases . 2 molecular nuclear medicine is a medical specialty using small amounts of radioactive materials called radiopharmaceuticals to diagnose and treat disease . in nuclear medicine imaging the radiopharmaceuticals are detected by special types of cameras pet and spect that work with computers to provide very precise pictures of the area of the body being imaged . nuclear medicine can be used to treat certain types of cancer and other diseases . 3 molecular imaging allows physicians to see how the body is functioning and to measure its chemical and biological processes . nuclear medicine procedures can often identify abnormalities very early in the progress of a disease long before many medical problems are apparent with other diagnostic tests . 4 contents 1 history 2 products 3 pipeline 4 millburn site controversy 5 references 6 external links history edit aaa was created in 2002 by italian physicist stefano buono to exploit a patent from the european organization for nuclear research cern . 5 today aaa trades on the nasdaq global select market under the ticker aaap . the first day of trading was 11 november 2015 . 6 the group currently has 22 production and research & development facilities that manufacture both diagnostic and therapeutic molecular nuclear medicine products and over 470 employees in 13 countries belgium france germany italy poland portugal spain switzerland the netherlands uk israel u.s. and canada . aaa s founder and ceo is stefano buono . aaa s board of directors includes yvonne greenstreet steven gannon christian merle leopoldo zambeletti stefano buono kapil dhingra 7 fran ois nader and claudio costamagna . 8 claudio costamagna has served as chairman since june 2012 . 9 aaa announced its full year results for 2015 with sales of 88.6 million 26.8 % vs. 2014 . 10 products edit aaa has a portfolio of diagnostic and therapeutic applications and products in the fields of molecular imaging and therapy . 11 the group s portfolio of radiopharmaceuticals includes radioactive agents for positron emission tomography pet imaging as well as single photon emission computed tomography spect diagnostic products . 12 pipeline edit aaa has a broad pipeline of products in development . the company s lead product in development phase iii lu dotatate lutathera is a theragnostic cancer product being developed to treat certain gastro entero pancreatic neuroendocrine tumors gep nets . 13 it selectively targets over expressed somatostatin receptors while also giving off gamma emissions to allow physicians to visualize where in the body both the drug and the tumor are . 14 lutathera was granted fast track designation by the us food and drug administration on 21 april 2015 for the treatment of progressive inoperable midgut nets . lutathera is currently administered on a compassionate use and named patient basis for the treatment of nets in ten european countries . somakit tate now marketed as netspot and somakit toc are novel kits in development for radiolabeling somatostatin analogue peptides to help diagnose somatostatin receptor positive net lesions . each kit has received orphan drug designation from both the ema and the fda . 15 16 in june 2016 the fda approved netspot somakit tate . somakit toc is being developed following the same regulatory path as that of netspot . the company submitted a maa to the ema for somakit toc in october 2015 . millburn site controversy edit aaa has purchased a site to open a light manufacturing site in millburn nj a residential town in north jersey . this caused substantial concerns among local residents . 17 residents expressed their opposition by signing an advocate on change.org . so far the website has collected more than 800 signatures . per the requests of millburn residents the township committee hired a nuclear radiology expert to re assess the appropriateness of opening a radioactive manufacturing site in the residential area . 18 the expert concluded that the proposed operations at aaa are safe and pose no hazard to the citizens of millburn . 19 20 references edit privateequitywire advanced accelerator applications completes fundraising feb 18th 2014 il sole 24 ore dal cern and biopark canavese march 12th 2014 snmmi about nuclear medicine & molecular imaging snmmi glossary of molecular imaging terms adnkronos research from rubbia to aaa great success for an italian physicist with european company . march 19th 2010 . insider monkey stocks hot on the market on wednesday 11 november . kathy mahdoubi . molecular imaging advanced accelerator applications keen on board consult from kapil dhingra . may 7 2014 . market watch kapil dhingra former head of roche oncology joins aaa board of directors april 29th 2014 mf dow jones claudio costamagna new chairman of aaa june 21st 2012 yahoo finance advanced accelerator applications reports 26.8 % sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms april 29th 2016 permanent dead link advanced accelerator applications nuclear medicine glossary medicaldevicedaily.com aaa to increase clinical trials of mnm diagnostic products febr 19th 2014 european pharmaceutical review aaa acquires ge healthcare s fdg pet radiopharmaceutical business in italy . 11 september . scrip intelligence aaa raises 41m to aid us expansion archived april 9 2014 at the wayback machine . . 17 february 2014 . devicespace.com advanced accelerator applications receives orphan drug designation from fda and european medicines agency for gallium 68 dotatate for use in patients with gastro entero pancreatic neuroendocrine tumors . 3 march 2014 . news medical aaa gets orphan drug designation status for radiopharmaceutical gallium 68 dotatate . 4 march 2014 . concerns raised about proposed cancer drug factory in millburn permanent dead link cecilia levine . nuclear meds expert hired . the record . 7 may 2015 . jonathan sym . advanced accelerator application investigation results risks are close to zero without being zero says expert . tap into millburn short hills . 18 february 2016 . harry trumbore . expert says radiopharmaceutical factory proposed for millburn is safe . the record . 11 february 2016 . external links edit official website global radiopharmaceutical market 2012 2016 da costa branquinho e. et al. 2013 . radiosynthesis and in vivo evaluation of fluorinated huprine derivates as pet radiotracers of acetylcholinesterase . nuclear medicine and biology . march 2013 priem t. et al. 2012 . synthesis and reactivity of a bis sultone cross linker for peptide conjugation and 18f radiolabelling via unusual double click approach.org biomol chem . 10 5 1068 78 remetti r. et al. 2011 . monte carlo simulation and radiometric characterization of proton irradiated 18 h2o for the treatment of the waste streams originated from 18f fdg synthesis process . applied radiation and isotopes 69 2011 1046 1051 insider monkey stocks hot on the market on wednesday 11 november . seeking alpha ipo preview advanced accelerator applications retrieved from https en.wikipedia.org w index.php title advanced accelerator applications & oldid 742622275 categories pharmaceutical companies2002 establishments in francehidden categories all articles with dead external linksarticles with dead external links from october 2016articles with permanently dead external linksarticles with wayback machine linkspages using infobox company with unsupported parameters navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages deutschespa olfran ais edit links this page was last modified on 4 october 2016 at 19 56 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view